BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, August 2, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

In the clinic for Feb. 3, 2020

Feb. 3, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Bio-Thera, Can-Fite, Corvus, Insmed, Moleculin, Regentree, Teva, United Therapeutics, Zynerba.
Read More

Financings for Feb. 3, 2020

Feb. 3, 2020
Biopharmas raising money in public or private financings, including: Cocrystal, CTI Biopharma, Denali, Passage Bio, Revolution Medicines, Xortx.
Read More

Appointments and advancements for Feb. 3, 2020

Feb. 3, 2020
New hires and promotions in the biopharma industry, including: Boston, Bryologyx, Contrafect, Cytomx, Galecto, Generex, Inceptua, Merck, Orchard, Phoremost, Portola, Respirerx, Verona.
Read More

Regulatory actions for Jan. 31, 2020

Jan. 31, 2020
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Olympus.
Read More

Other news to note for Jan. 31, 2020

Jan. 31, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief:Candela, Coborn’s, Co-Diagnostics, Desert Medical Imaging, Halo Dx, Mckesson, MT. Derm, Neovasc, Oxford Nanopore Technologies, Proscan Imaging, Siemens Healthineers, Valgenesis.
Read More

Appointments and advancements for Jan. 31, 2020

Jan. 31, 2020
New hires and promotions in the med-tech industry, including: Vapotherm.
Read More

Financings for Jan. 31, 2020

Jan. 31, 2020
Med-tech firms raising money in public or private financings, including: 1Life Healthcare, Itamar Medical, Medx Health, Microbix Biosystems, Nephros.
Read More

Regulatory actions for Jan. 31, 2020

Jan. 31, 2020
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbvie, Alnylam, Bayer, Daiichi Sankyo, Emergent Biosolutions, Lilly, Novo Nordisk, Pfizer, Seattle Genetics.
Read More

Other news to note for Jan. 31, 2020

Jan. 31, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aspen, Curevac, Follicum, Fuzionaire, ICER, Nanoviricides, Novartis, Predictive Oncology, Quantitative Medicine, Saromics, Vaxart, Ziopharm.
Read More

In the clinic for Jan. 31, 2020

Jan. 31, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Kyowa Kirin, Rani, Ziopharm.
Read More
Previous 1 2 … 1731 1732 1733 1734 1735 1736 1737 1738 1739 … 1830 1831 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 31, 2026.
  • HIV virus

    AIDS 2026: New targets for metabolic dysfunction despite ART

    BioWorld
    Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
  • Jingxin discloses new muscarinic and sigma receptor agonists

    BioWorld Science
    Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
  • Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors

    BioWorld Science
    Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
  • Silhouette illustration of DNA gene editing

    Death in Chinese gene-editing trial exposes ethical fault lines

    BioWorld
    The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
    • Videos
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing